News
Drug Substance Freezing and Why It Doesn’t Have To Be a Bottleneck
Drug substance freezing has moved on.
Traditionally it was inefficient in a multitude of ways. Issues such as product loss, reduction of product potency, or...
News
Rapid Development and Industrialization of a COVID-19 Viral Vector Vaccine Manufacturing Process
The year 2020 will go down in history books as a year that changed the world and helped drug manufacturing to evolve. When the...
News
Agilex Biolabs Partners with Endpoints News for the First Webinar on Rapid Vaccine Development in Australia
Agilex Biolabs, the Australian specialist bioanalytical and toxicology laboratory facilities for clinical trials is partnering with Endpoints News to share the latest on "Non-clinical...
News
Nucleome Unveils South Asia’s Largest and Most Advanced Genomics Research Centre; To Sequence 5000 COVID Genomes
In a move that will mark the beginning of a new era in India’s genomics capability, Nucleome Informatics today unveiled South Asia’s largest and...
News
BOMI Group joins the Veratrak-led Integrated Warehouse Project aimed at connecting HLS companies with their LSP partners
UK-based software provider to the life science industry, Veratrak, has announced a collaboration with BOMI Group.
BOMI Group operates in the field of logistics and...
News
DFE Pharma Proudly Supports COVID-19 Vaccination Supply in Pakistan
DFE Pharma, a global leader in pharmaceutical excipient solutions, is proud to announce its collaboration with AJM Pharma as a key supplier with BioHale®...
IT & Data Management
CluePoints partners with ZS to provide best-in-class RBQM expertise and technology, increasing clinical trial efficiency and improving patient outcomes
CluePoints, the premier provider of risk-based quality management (RBQM) and data oversight software for clinical trials, has partnered with ZS, a global professional services...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
















